[1] Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update2009[J]. Thorax,2009,64 Suppl 3:iii1-55.
[2] Leeper KV Jr.Severe community-acquired pneumonia[J]. Semin Respir Infect,1996,11(2):96-108.
[3] Bauer TT, Ewig S, Marre R, et al.CRB-65 predicts death from community-acquired pneumonia[J]. J Intern Med,2006, 260:93-101.
[4] Capelastegui A, España PP, Quintana JM, et al.Validation of a predictive rule for the management of community-acquired pneumonia[J]. Eur Respir J,2006,27(1):151-157.
[5] Barlow G, Nathwani D, Davey P.The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia[J]. Thorax,2007,62(3):253-259.
[6] Man SY, Lee N, Ip M, et al.Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong[J]. Thorax,2007, 62(4):348-353.
[7] Zuberi FF, Khan JA.Prospective comparison of prediction rules of mortality risk for CAP in a developing country[J]. Int J Tuberc Lung Dis,2008,12(4):447-452.
[8] Schuetz P, Koller M, Christ-Crain M, et al.Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings[J]. Epidemiol Infect,2008,136(12):1628-1637.
[9] Menéndez R, Martínez R, Reyes S, et al.Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia[J]. Thorax,2009,64(7):587-591.
[10] Karmakar G, Wilsher M.Use of the 'CURB 65' score in hospital practice[J]. Intern Med J,2010,40(12):828-832.
[11] Ronan D, Nathwani D, Davey P, et al.Predicting mortality in patients with community-acquired pneumonia and low CURB-65 scores[J]. Eur J Clin Microbiol Infect Dis,2010,29(9):1117-1124.
[12] Dwyer R, Hedlund J, Darenberg J, et al.Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia[J]. Scand J Infect Dis,2011,43(6-7):448-455.
[13] Guo Q, Li HY, Zhou YP, et al.Weight of the CURB-65 criteria for community-acquired pneumonia in a very low-mortality-rate setting[J]. Intern Med,2012,51(18):2521-2527.
[14] Nüllmann H, Pflug MA, Wesemann T, et al.External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia[J]. BMC Infect Dis,2014,14:39.
[15] Aujesky D, Auble TE, Yealy DM, et al.Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia[J]. Am J Med,2005, 118(4):384-392.
[16] Challen K, Bright J, Bentley A, et al.Physiological-social score (PMEWS) vs. CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy[J]. BMC Health Serv Res,2007,7:33.
[17] Ananda-Rajah MR, Charles PG, Melvani S, et al.Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia[J]. Scand J Infect Dis,2008,40(4):293-300.
[18] Charles PG, Wolfe R, Whitby M, et al.SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia[J]. Clin Infect Dis,2008,47(3):375-384.
[19] Shindo Y, Sato S, Maruyama E, et al.Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia[J]. Respirology,2008,13(5):731-735.
[20] Claessens YE, Mathevon T, Kierzek G, et al.Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia[J]. Intensive Care Med,2010,36(5):799-809.
[21] España PP, Capelastegui A, Quintana JM, et al.Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia[J]. J Infect,2010,60(2):106-113.
[22] Abisheganaden J, Ding YY, Chong WF, et al.Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index[J]. Respirology,2012,17(6):969-975.
[23] Luque S, Gea J, Saballs P, et al.Prospective comparison of severity scores for predicting mortality in community-acquired pneumonia[J]. Rev Esp Quimioter,2012,25(2):147-154.
[24] Kim HI, Kim SW, Chang HH, et al.Mortality of community-acquired pneumonia in Korea: assessed with the pneumonia severity index and the CURB-65 score[J]. J Korean Med Sci,2013,28(9):1276-1282.
[25] Mbata GC, Chukwuka CJ, Onyedum CC, et al.The CURB-65 scoring system in severity assessment of Eas-tern Nigerian patients with community-acquired pneumonia: a prospective observational study[J]. Prim Care Respir J,2013,22(2):175-180.
[26] Alavi-Moghaddam M, Bakhshi H, Rezaei B, et al.Pneumonia severity index compared to CURB-65 in predicting the outcome of community acquired pneumonia among patients referred to an Iranian emergency department: a prospective survey[J]. Braz J Infect Dis,2013,17(2):179-183.
[27] Ribeiro C, Ladeira I, Gaio AR, et al.Pneumococcal pneumonia-Are the new severity scores more accurate in predicting adverse outcomes?[J]. Rev Port Pneumol,2013, 19(6):252-259.
[28] Varshochi M, Kianmehr P, Naghavi-Behzad M, et al.Correspondence between hospital admission and the pneumonia severity index(PSI), CURB-65 criteria and comparison of their predictive value in mortality and hospital stay[J]. Infez Med,2013,21(2):103-110.
[29] Yin Q, Liu B, Chen Y, et al.Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia[J]. Inflammation 2014,37(4):1271-1279.
[30] van der Eerden MM, de Graaff CS, Bronsveld W, et al. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia[J]. Respir Med,2004,98(9):872-878.
[31] Mortensen EM, Restrepo MI, Anzueto A, et al.The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia[J]. Respir Res,2005,6:82.
[32] Ortega L, Sierra M, Domínguez J, et al.Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia[J]. Scand J Infect Dis,2005,37(9):657-663.
[33] Buising KL, Thursky KA, Black JF, et al.A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia[J]. Thorax,2006,61(5):419-424.
[34] Naito T, Suda T, Yasuda K, et al.A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia[J]. J Am Geriatr Soc,2006,54:1212-1219.
[35] Renaud B, Coma E, Hayon J, et al.Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study[J]. Clin Microbiol Infect,2007,13(9):923-931.
[36] Huang DT, Weissfeld LA, Kellum JA, et al.Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia[J]. Ann Emerg Med,2008,52(1):48-58.
[37] Johnstone J, Eurich DT, Majumdar SR, et al.Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study[J]. Medicine (Baltimore),2008,87(6):329-334.
[38] Chen CZ, Fan PS, Lin CC, et al.Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia[J]. J Formos Med Assoc,2009,108(3):219-223.
[39] Robins-Browne KL, Cheng AC, Thomas KA, et al.The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study[J]. Trop Med Int Health,2012, 17(7):914-919
[40] Suberviola B, Castellanos-Ortega A, Llorca J, et al.Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia[J]. Swiss Med Wkly,2012,142:w13542.
[41] Kohno S, Seki M, Takehara K, et al.Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study[J]. Respiration,2013,85(1):27-35.
[42] Fernandez-Botran R, Uriarte SM, Arnold FW, et al.Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia[J]. Inflammation,2014, 37(4):1158-1166.
[43] Davis JS, Cross GB, Charles PG, et al.Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply?[J]. Med J Aust,2010,192(3):133-136.
[44] Phua J, See KC, Chan YH, et al.Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia[J]. Thorax,2009,64(7):598-603.
[45] Park SY, Park S, Lee MG, et al.Minor criteria of Infectious Disease Society Of America/American Thoracic Society for severe community-acquired pneumonia can predict delayed treatment response[J]. J Korean Med Sci,2012,27(8):907-913.
[46] Garau J, Baquero F, Pérez-Trallero E, et al.Factors impacting on length of stay and mortality of community-acquired pneumonia[J]. Clin Microbiol Infect,2008,14(4):322-329.
[47] Chalmers JD, Singanayagam A, Akram AR, et al.Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis[J]. Thorax,2010,65(10):878-883.
[48] Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study[J]. Thorax,2003,58(5):377-382.
[49] Serisier DJ, Williams S, Bowler SD.Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia[J]. Respirology,2013,18(2):291-296.
[50] Eccles S, Pincus C, Higgins B, et al.Diagnosis and mana-gement of community and hospital acquired pneumonia in adults: summary of NICE guidance[J]. BMJ,2014,349:g6722.
[51] 余跃天, 朱琤, 毛恩强, 等. 阿托伐他丁对缺血性脑卒中患者医院获得性肺炎的影响[J]. 诊断学理论与实践,2015,14(2):169-174.
[52] Singanayagam A, Chalmers JD, Hill AT.Severity assessment in community-acquired pneumonia: a review[J]. QJM,2009,102(6):379-388.
[53] Marti C, Garin N, Grosgurin O, et al.Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis[J]. Crit Care,2012,16(4):R141.
[54] Riquelme R, Jiménez P, Videla AJ, et al.Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia[J]. Int J Tuberc Lung Dis,2011,15(4):542-546.
[55] Bjarnason A, Thorleifsdottir G, Löve A, et al.Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, po-pulation-based study[J]. PLoS One,2012,7(10):e46816.
[56] Myles PR, Nguyen-van-Tam JS, Lim WS, et al. Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data[J]. PLoS One,2012,7(4):e34428.
[57] Muller MP, McGeer AJ, Hassan K, et al. Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza[J]. PLoS One,2010,5(3):e9563.
[58] 尹玉东, 曹彬. 社区获得性肺炎诊治指南解读: 从病情严重度分层角度[J]. 中国循证医学杂志,2015,15(7):756-760.